Several independent studies have demonstrated that individuals with germline mutations in BRCA2 are at increased risk of prostate cancer (The Breast Cancer Linkage Consortium, 1999; Edwards et al, 2003; Giusti et al, 2003). The gene discussed is BRCA2; the disease is prostate cancer.